Stay updated with breaking news from Brain Stimulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medtronic, a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
Brief TMS can boost an individual's hypnotizability, in new findings that may increase the efficacy of therapeutic hypnosis and expand the pool of patients benefiting from it.
Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN, Jan. 8, 2024...
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its...
The job roles offered after pursuing the course include Educators, Linguistic analysts, Data analysts, Product developers/designers, AI engineers, Cognitive rehabilitation, Robotics.